Self-driving labs for biotechnology
- PMID: 41034460
- DOI: 10.1038/s43588-025-00885-8
Self-driving labs for biotechnology
Conflict of interest statement
Competing interests: D.G.A. receives research funding from Sanofi and is a founder of Orna Therapeutics, Soufflé Therapeutics and Combined Therapeutics. R.L. is a co-founder and former member of the board of directors of Moderna. He also serves on the board and has equity in Particles for Humanity. For a full list of entities with which R.L. is involved, compensated or uncompensated, see https://www.dropbox.com/scl/fi/ty2b7x8vyebid8ybcbeox/Rev-Langer-COI.pdf?rlkey=lko2srm1qjknm53ck9yns1dfj&e=1&dl=0 . E.C. has no competing interests to declare.
References
-
- Abolhasani, M. & Kumacheva, E. Nat. Synth. 2, 483–492 (2023). - DOI
-
- Martin, H. G. et al. Curr. Opin. Biotechnol. 79, 102881 (2023). - DOI
-
- Rapp, J. T., Bremer, B. J. & Romero, P. A. Nat. Chem. Eng. 1, 97–107 (2024). - DOI
-
- Coley, C. W. et al. Science 365, eaax1566 (2019). - DOI
-
- Packer, M. S. & Liu, D. R. Nat. Rev. Genet. 16, 379–394 (2015). - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
